Q4 Results 2025 Highlights: Piramal Enterprises posts loss of Rs 23.33 crore; HPCL profit up 18.02%

o Operating 517 branches, serving 428 cities across 26 states.

o Customer franchise grew 24% YoY to 4.7 mn.

o 16 Direct Assignment & Co-lending partnerships, including the largest PSU bank, two of the top-3 private sector banks and the largest NBFC.

o A transformative year in digital engagement, service, collections and investment in brand for long term.

In Q4FY25, PCHFL, a subsidiary of PEL, was renamed Piramal Finance Limited (PFL) and transitioned from a Housing Finance Company (HFC) to a Non-Banking Financial Company (NBFC).

o PFL is now an Upper Layer NBFC and one of top-10 private sector NBFCs in India.

o The company also received Reserve Bank of India (RBI) approval for the merger of PEL with PFL and have initiated the National Company Law Tribunal (NCLT) process for approvals, which is expected to conclude around September 2025.

Piramal Enterprises on Tuesday released its fiscal fourth quarter earnings report with Q4 standalone loss at Rs 23.33 crore as against a profit of Rs 953.54 crore recorded during the corresponding quarter of FY24. The net interest income (NII) stood at Rs 245 crore, down 6.5 per cent on-year.

While gross NPA remained flat at 2.8 per cent on-quarter, net NPA was recorded at 1.9 per cent vs 1.5 per cent QoQ.

For FY25, HPCL achieved its highest-ever refinery throughput of 25.27 MMT. Visakh Refinery was able to realise the full volume potential post the expansion and processed over 15 MMT of crude oil. Similarly, Mumbai Refinery processed almost 10 MMT crude oil at an all-time high. HPCL also registered record-high sales volume of 49.82 MMT. Additionally, HPCL also recorded its highest-ever pipeline throughput of 26.90 MMT during FY 2024-25.

• Revenue from Operations: Rs 4,66,346 crore (Rs 4,61,638 crore in FY24)

• Gross Refining Margin (GRM): US$ 5.74 per barrel (US$ 9.08 per barrel in FY24)

• Profit After Tax (PAT): Rs 7,365 crore (Rs 14,694 crore in FY24)

• Consolidated PAT: Rs 6,736 crore (Rs 16,015 crore in FY24)

Hindustan Petroleum Corporation Ltd (HPCL) on Tuesday released its fiscal fourth quarter earnings report with standalone profit at Rs 3,354.98 crore, posting a growth of 18.02 per cent in comparison to Rs 2,842.75 crore recorded during the corresponding quarter of FY24. Revenue from operations stood at Rs 1,18,334 crore. The company reported total income for the quarter under review at Rs 1,19,126.13 crore, posting a drop of 2.66 per cent as against Rs 1,22,386.14 crore reported during the fourth quarter of previous financial year.

In line with the trends seen in previous 3 quarters, Q4FY25 ESOP cost was lower at Rs 169 crore, on account of ESOP lapses at the time of employee separation during the quarter. Our FY25 ESOP cost was Rs 815 crore versus expected charge of Rs 1,176 crore disclosed in Q4FY24 earnings release. On April 16, 2025, Founder and CEO Vijay Shekhar Sharma had informed the company that he has voluntarily forgone all 2.1 crore ESOPs granted to him. The NRC has treated these ESOPs as cancelled and the same have been returned back to the ESOP pool. This, the company said, will result in a one-time, non-cash, acceleration of ESOP expense of Rs 492 crore in Q4FY25, and an equivalent lowering of ESOP expenses in future years.

Starting from Q1FY26, ESOP cost will be substantially lower with Q1FY26 ESOP cost estimated to be in the range of Rs 75-100 crore as against Rs 169 crore in Q4FY25.

“Consequent to the above and as per IND AS 102, entire cost of the underlying ESOP grant amounting to Rs 4,092 Cr (recorded in the Statement of Profit and Loss from FY 2022 to FY 2025), has been credited back to Retained Earnings of the Company and therefore, has increased the free reserves of the Company,” it said in a regulatory filing.

Paytm on Tuesday released its fiscal fourth quarter earnings report wherein it reported loss marginally narrowed to Rs 539.80 crore in comparison to a loss of Rs 549.60 crore recorded during the corresponding quarter of FY24. It posted revenue from operations at Rs 1911.50 crore, posting a decline of 15.69 per cent as against Rs 2267.10 crore reported during the fourth quarter of previous financial year.

Safari Industries India Ltd on Tuesday released its fiscal fourth quarter earnings report with profit at Rs 37.59 crore, reporting a drop of 12.97 per cent in comparison to Rs 43.19 crore recorded during the corresponding quarter of FY24. It posted revenue from operations at Rs 421.06 crore, up 15.23 per cent as against Rs 365.42 crore reported during the fourth quarter of previous financial year. The company EBITDA stood at Rs 61 crore, down 9 per cent YoY.

Vedant Fashions Ltd, known for its brands Manyavar and Mohey, on Tuesday released its fiscal fourth quarter earning report with profit at Rs 101.11 crore, posting a drop of 12.68 per cent in comparison to Rs 115.79 crore recorded during the corresponding quarter of FY24. It posted revenue from operations at Rs 367.44 crore, up 1.18 per cent as against Rs 363.16 crore recorded during the fourth quarter of previous financial year. The company EBITDA stood at Rs 165.7 crore, down 5.3 per cent.

- The Gross NPA of the Bank reduced by 12.6% YoY to Rs 27,835 crore in FY25 and Gross NPA Ratio improved to 2.26% in FY25 from 2.92% in FY24.

- The Net NPA Ratio of the Bank stands at 0.58% in FY25 as compared with 0.68% in FY24.

- The Provision Coverage Ratio of the Bank stood at 93.29% including TWO and 74.87% excluding TWO for FY25.

- Slippage ratio declined to 0.78% for FY25 as against 0.99% in FY24.

- Credit cost stands at 0.47% for FY25.

The company board recommended a dividend at Rs 8.35 per equity share at face value of Rs 2 each fully paid up for FY2024-25. The Bank has fixed record/cut off date as 06th June 2025 for the purpose of dividend payment.

The company board has recommended a final dividend of Rs 4 per equity share of face value of Re 1 each for the financial year ended March 31, 2025. The said final dividend, if approved by the members of the Company at the ensuing Annual General Meeting (AGM) of the company, will be paid/dispatched within 30 days of its declaration at the said AGM of the Company,” the company said in a regulatory filing.

Shaunak Amin, MD, Alembic Pharmaceuticals Limited, said, “India-Branded Business displayed improved performance, backed by Specialty therapies. While the Animal Health division continued to outperform through a strong portfolio of trusted brands. By deepening our engagement with healthcare professionals and expanding our product pipeline, we have laid a solid foundation for strong, consistent growth, going forward. Our Ex-US business delivered a strong growth of 43% across all markets whereas the US business grew by 20% during the quarter.”

Alembic Pharmaceuticals Ltd on Tuesday released its fiscal fourth quarter earnings report with profit at Rs 156.89 crore, posting a decline of 11.96 per cent in comparison to Rs 178.21 crore recorded during the corresponding quarter of FY24. It posted revenue from operations at Rs 1,769.64 crore, up 16.66 per cent as against Rs 1,516.98 crore reported during the fourth quarter of previous financial year. The company EBITDA stood at Rs 272 crore, up 4.6 per cen on-year.

The company board has recommended a dividend @ 350 per cent i.e. Rs 35 per equity share of face value of Rs 10 each for the financial year 2024-25 subject to approval of members at the ensuing Annual General Meeting. “The dividend, if approved by the members in the ensuing Annual General Meeting will be paid on or before 30 days from the date of Annual General Meeting. The book closure and record date for dividend purpose will be intimated in due course,” it said in a regulatory filing.